CSIMarket
 
Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 
 

Casi Pharmaceuticals Inc Income Statement Quarterly

CASI


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Service Revenue - - - -
Revenue From Contract With Customer Excluding Assessed Tax - - - 8.08
Lease Income - - - 0.04
Total Revenue 0.00 0.00 0.00 9.16 8.11
Cost of Goods and Services Sold - - - 0.56 1.83
Gross Profit 0.00 0.00 0.00 3.77 6.28
Selling, Administration, Marketing - - - 12.78 8.69
Gain (Loss) on Disposition of Assets and Other Investments - - - -0.07 -
Depriciation & Amortization - - - - -
Research and Development Expense (Excluding Acquired in Process Cost) - - - 4.01 2.90
Impairment of Intangible Assets, Finite-lived - - - - -
Other operatinig exp. /-income - - - -1.11 0.00
Unusual Expense /-Income - - - - -
Royalty Costs - - - 4.36 1.59
Total operating costs including COS - - - 20.53 15.00
Operating income/-loss - - - -11.37 -6.89
Other Deductions / - Income
Interest expense - - - 0.06 0.08
Interest income - - - - -
Net interest expense/-income - - - 0.06 0.08
Loss (Income) from Equity Method Investments - - - - -
Foreign Currency Transaction Gain (Loss), before Tax - - - 0.02 0.01
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income - - - -6.06 -0.65
Equity Securities Fv Ni Unrealized Gain Loss - - - - 3.69
Total costs & expenses 0.00 0.00 0.00 14.55 18.13
Income /-loss before income taxes 0.00 0.00 0.00 -5.40 -10.02
Income taxes expenses/-benefit - - - - -
Income after income taxes 0.00 0.00 0.00 -5.40 -10.02
Net income/-loss of other equity - - - - -
Income/-loss from cont. Ops. 0.00 0.00 0.00 -5.40 -10.02
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss 0.00 0.00 0.00 -5.40 -10.02
Noncontrolling interests - - - 0.28 -0.31
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder 0.00 0.00 0.00 -5.60 -10.22
EBIT 0.00 0.00 0.00 -5.34 -9.94
EBITD 0.00 0.00 0.00 -5.26 -9.85
EBITDA 0.00 0.00 0.00 -5.26 -9.85


Per Share (GAAP Quarterly, in $) 0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Basic EPS (excl. extra items) 0.00 0.00 0.00 -0.04 -0.07
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS 0.00 0.00 0.00 -0.04 -0.07
Basic shares outstanding (Mill. of Units) 0.00 0.00 0.00 140.00 139.80
   EPS other shares - - - - -
Diluted Net EPS 0.00 0.00 0.00 -0.04 -0.07
Diluted average shares (Mill. of Units) 13.65 13.65 13.65 140.00 139.80
Dividend per share - - - - -



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com